Lidamidine API is a synthetic small-molecule pharmaceutical compound belonging to the substituted urea / amidino-urea class. It is chemically identified as 1-(2,6-dimethylphenyl)-3-(N′-methylcarbamimidoyl)urea and is also described by the systematic designation 1-(methylamidino)-3-(2,6-xylyl)urea. Lidamidine has the molecular formula C₁₁H₁₆N₄O, molecular weight 220.27 g/mol, and primary CAS number 66871-56-5.
Lidamidine has been investigated and used as a pharmacologically active gastrointestinal compound, particularly because of its effects on intestinal secretion and gastrointestinal function. Its pharmacological profile has been associated with inhibition of intestinal fluid secretion and modulation of gastrointestinal activity.
The compound is structurally characterized by a 2,6-dimethylphenyl group attached to a substituted urea framework containing an amidino functionality. It has no defined stereocenters, making stereochemical specification generally unnecessary for the free-base compound. PubChem reports zero defined and undefined atom stereocenters.
Lidamidine has also been represented in pharmaceutical databases under the INN Lidamidine and has been assigned the UNII Q8X04W8418.
MEDIOCON INC supplies Lidamidine for applicable pharmaceutical research, formulation development, analytical investigation, quality-control applications and bulk API requirements, subject to product availability, applicable regulatory requirements and supporting documentation.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Lidamidine API Manufacturer & Supplier in India | MEDIOCON INC (CAS 66871-56-5) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Lidamidine API Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance